Hypoxia-inducible factor-1α: a promising therapeutic target for autoimmune diseases
- 29 May 2017
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 21 (7) , 715-723
Abstract
Introduction: Hypoxia-inducible factor-1α (HIF-1α) plays a crucial role in both innate and adaptive immunity. Emerging evidence indicates that HIF-1α is associated with the inflammation and pathologic activities of autoimmune diseases. Areas covered: Considering that the types of autoimmune diseases are complicated and various, this review aims to cover the typical kinds of autoimmune diseases, discuss the molecular mechanisms, biological functions and expression of HIF-1α in these diseases, and further explore its therapeutic potential. Expert opinion: Inflammation and hypoxia are interdependent. HIF-1α as a key regulator of hypoxia, exerts a crucial role in the balance between Th17 and Treg, and involves in the inflammation and pathologic activities of autoimmune diseases. Although there are many challenges remaining to be overcome, targeting HIF-1α could be a promising strategy for autoimmune diseases therapies.Keywords
Funding Information
- National Natural Science Foundation of China (81373073, 81573222, 81671611)
This publication has 102 references indexed in Scilit:
- Hypoxia-inducible factor-1 alpha–dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosaProceedings of the National Academy of Sciences, 2012
- Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1Cell, 2011
- HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cellsJournal of Experimental Medicine, 2011
- Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growthProceedings of the National Academy of Sciences, 2008
- IL-33 exacerbates antigen-induced arthritis by activating mast cellsProceedings of the National Academy of Sciences, 2008
- HCG up-regulates hypoxia inducible factor-1 alpha in luteinized granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteumMolecular Human Reproduction, 2008
- Mucosal Protection by Hypoxia-Inducible Factor Prolyl Hydroxylase InhibitionGastroenterology, 2008
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?Brain, 2007
- Inflammatory bowel disease: past, present, and futureJournal of Gastroenterology, 2007